Although there appeared to be a tendency towards more frequent diagnosis of pulmonary embolism at admission (a higher proportion of DPP-4I compared to the whole-group of non-users, and statistically significant compared with the non-DPP-4I insulin users), there was no difference in the incidence of this diagnosis at hospital discharge. The gene discussed is INS; the disease is pulmonary embolism.